Citation
86 FR 42843
Multiple canonical documents share this first-page citation.
- Determination That VOTRIENT (Pazopanib Hydrochloride) Tablets, 400 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness Thursday, August 5, 2021 86 FR 42843
- Remanufacturing of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period Thursday, August 5, 2021 86 FR 42843